In this study, we examined the clinical implications of the variables, TIPRL, LC3, CD133, and CD44, all of which have been reported on in terms of their roles in liver cancers and autophagy, including hepatocellular carcinomas (HCCs) and intrahepatic cholangiocarcinomas (iCCA). This evidence concerns the gene PROM1 and liver cancer.